TY - JOUR AU - Fretz, Rainer AU - Negro, Francesco AU - Bruggmann, Philip AU - Lavanchy, Daniel AU - De Gottardi, Andrea AU - Pache, Isabelle AU - Masserey Spicher, Virginie AU - Cerny, Andreas PY - 2013/05/05 Y2 - 2024/03/29 TI - Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection JF - Swiss Medical Weekly JA - Swiss Med Wkly VL - 143 IS - 1920 SE - Review article: Biomedical intelligence DO - 10.4414/smw.2013.13793 UR - https://smw.ch/index.php/smw/article/view/1681 SP - w13793 AB - <p><p>Hepatitis B and hepatitis C are contagious liver diseases caused by the hepatitis B virus (HBV) and the hepatitis C virus (HCV), respectively. In particular, chronic infection with HBV or HCV is a major public health problem throughout Europe. The majority of persons chronically infected (65%–75%) are not aware of their infection status until symptoms of advanced liver disease appear. In addition, the peak in the number of patients suffering from advanced stages of the disease, such as cirrhosis and hepatocellular carcinoma, has not yet been reached. In order to reduce the current and future morbidity and mortality associated with chronic HBV or HCV infection, the timely detection of chronically infected persons, with follow-up and case management, is crucial. However, the current screening strategies in Europe and Switzerland have to be considered as inadequate to detect the majority of chronically infected persons. Hence, we emphasise the importance of an alternative approach: the healthcare provider initiated identification of HBV or HCV infection in defined risk groups. This entails determining whether a person is not only at risk of being chronically infected, but also at risk of becoming infected with HBV or HCV and, if necessary, testing for HBV or HCV infection.</p></p> ER -